Fundraising FoxArboretum Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
SonarMD provides a care management platform for chronic diseases, starting with gastroenterology, that combines AI technology with human support to detect clinical deterioration early and help specialists intervene before emergencies.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSaaSChicago, US
Lawrence R. Kosinski(Founder and Board Member)inBETH HOUCK(Executive Officer, Director)inJohn Starr(Executive Officer)Devin Gross(Executive Officer, Director)
Board seatCharity TarnThomas M ShehabTom Shehab· per SEC Form D
Co-investorsBlue Hour VenturesHypothesisNueterra CapitalTensility Venture PartnersBlueCross BlueShield Venture Partners
Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Matthew Cooper(CEO & Co-founder)inElaine Heron(Director)
BoardDan Kidle(Director)inSundaresh Brahmasandra(Director)
Co-investorsSand Hill AngelsStartX
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid.
BiotechDeep TechHealthtechMedical Devices
Mark Wagner(Founder, Investor, & Director in Pharaoh)inDr. Nandan Lad(Chief Medical Officer & Co-Founder)Rich Nazarian(Founder, Investor, & Director in Pharaoh)inAmaza Reitmeier(Chief Executive Officer, Director)in
Co-investorsHatteras Venture PartnersIAG Capital PartnersLaerdal Million Lives Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.